FDA OK's Flonase for Sale Over the Counter in U.S.
July 24 2014 - 1:40PM
Dow Jones News
LONDON--GlaxoSmithKline PLC (GSK.LN) said Thursday that the U.S.
Food and Drug Administration has approved Flonase Allergy Relief as
an over-the-counter treatment for temporary relief of the symptoms
of hay fever or upper respiratory allergies.
The U.K. drug maker said Flonase Allergy Relief will be
available over the counter in early 2015.
GlaxoSmithKline shares closed Thursday at GBP14.70, valuing the
company at GBP71.25 billion.
Write to Razak Musah Baba at razak.baba@wsj.com; Twitter:
@Raztweet
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
GSK (NYSE:GSK)
Historical Stock Chart
From Mar 2024 to Apr 2024
GSK (NYSE:GSK)
Historical Stock Chart
From Apr 2023 to Apr 2024